Matches in Wikidata for { <http://www.wikidata.org/entity/Q93604843> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q93604843 description "article scientifique publié en 2012" @default.
- Q93604843 description "im August 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93604843 description "scholarly article published in Genetics in Medicine" @default.
- Q93604843 description "wetenschappelijk artikel" @default.
- Q93604843 description "наукова стаття, опублікована в серпні 2012" @default.
- Q93604843 name "CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)" @default.
- Q93604843 name "CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)" @default.
- Q93604843 type Item @default.
- Q93604843 label "CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)" @default.
- Q93604843 label "CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)" @default.
- Q93604843 prefLabel "CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)" @default.
- Q93604843 prefLabel "CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)" @default.
- Q93604843 P1433 Q93604843-AECEEF3C-0BD5-47EA-B256-3B7CF0BC8BC8 @default.
- Q93604843 P1476 Q93604843-F7A9B884-3913-4CF6-83F7-7F04E45A0E1E @default.
- Q93604843 P304 Q93604843-35E1E4F4-91A2-4D6E-B13B-94CDD7AD4E79 @default.
- Q93604843 P31 Q93604843-6E480241-F567-4EE6-97E6-FE42BE526CE2 @default.
- Q93604843 P31 Q93604843-C571DB6B-7FC5-4B8E-8350-1F19A445FF99 @default.
- Q93604843 P356 Q93604843-3FE69459-393B-4B84-86CC-D820FABAB3E7 @default.
- Q93604843 P433 Q93604843-BBA72DB6-9E41-4F7A-95FF-9055E2225F75 @default.
- Q93604843 P478 Q93604843-22033E92-0710-4BCB-BF1B-CF3FED136C49 @default.
- Q93604843 P577 Q93604843-EC079BAA-3E56-4B86-8910-69A01E27360C @default.
- Q93604843 P921 Q93604843-39FF5809-4351-4134-8DF7-12FF08D5D9BB @default.
- Q93604843 P932 Q93604843-FED1B590-A5AC-444E-A7B5-9225BF5B3E4C @default.
- Q93604843 P356 GIM.2012.62 @default.
- Q93604843 P1433 Q15765508 @default.
- Q93604843 P1476 "CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)" @default.
- Q93604843 P304 "762-762" @default.
- Q93604843 P31 Q13442814 @default.
- Q93604843 P31 Q1348305 @default.
- Q93604843 P356 "10.1038/GIM.2012.62" @default.
- Q93604843 P433 "8" @default.
- Q93604843 P478 "14" @default.
- Q93604843 P577 "2012-08-03T00:00:00Z" @default.
- Q93604843 P921 Q615645 @default.
- Q93604843 P932 "4030589" @default.